geninus Venture Capital
3 known investors
Geninus develops IntelliMed, a platform that uses multimodal spatial transcriptomics and patient data to discover novel drug targets for oncology, particularly for modalities like TCEs and ADCs. The platform combines spatial genomics, protein profiling, and clinical outcomes to enable target discovery with reduced biological risk.
Founders & leadership
WY
Woong Yang Park
Investors · 3
Frequently asked questions
- What does geninus Venture Capital do?
- Geninus develops IntelliMed, a platform that uses multimodal spatial transcriptomics and patient data to discover novel drug targets for oncology, particularly for modalities like TCEs and ADCs. The platform combines spatial genomics, protein profiling, and clinical outcomes to enable target discovery with reduced biological risk.
- Who founded geninus Venture Capital?
- geninus Venture Capital was founded by Woong Yang Park.
- Who are geninus Venture Capital's investors?
- geninus Venture Capital's investors include Aju IB Invesment Corporation, IMM Investment Japan, Solidus Investment.